Obsidian Therapeutics logo

Obsidian Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States51-200 Employees

Obsidian Therapeutics is a biotechnology company focused on developing controllable cell and gene therapies to improve outcomes for patients with difficult-to-treat diseases. The company uses cytoDrive technology to regulate protein expression in its therapeutic cell and gene products, aiming to enhance efficacy. Its lead program, cytoTIL15, is designed to improve the activity of tumor-infiltrating lymphocytes in solid tumors.
Headquartered in Cambridge, Massachusetts, with a laboratory facility in Bedford, Massachusetts, it is mid-sized. In 2024, Obsidian Therapeutics completed a merger with Galera Therapeutics, a development that aligns its oncology-focused engineered TIL therapy pipeline for solid tumors. The organization operates in the biotechnology research industry, pursuing cell and gene therapy solutions to address areas of unmet clinical need.

Find Obsidian Therapeutics employees' phone numbers or email addresses

Obsidian Therapeutics Global Highlights

Location
Employees

North America
119

Minus sign iconPlus sign icon
  • United States Of America
    119

Europe
1

Minus sign iconPlus sign icon
  • Denmark
    1

Obsidian Therapeutics's Leadership

  • Vice President Clinical Pharmacology; Toxicology; Quantitative Sciences at Obsidian Therapeutics
    G. H.
    Vice President Clinical Pharmacology; Toxicology; Quantitative Sciences
  • Vice President, Clinical Operations & Translational Early Clinical Development at Obsidian Therapeutics
    P. P.
    Vice President, Clinical Operations & Translational Early Clinical Development
  • Senior Vice President Head Of Research at Obsidian Therapeutics
    S. S.
    Senior Vice President Head Of Research
  • Director Regulatory Affairs Cmc at Obsidian Therapeutics
    T. H.
    Director Regulatory Affairs Cmc
  • Director Regulatory Affairs Cmc at Obsidian Therapeutics
    T. H.
    Director Regulatory Affairs Cmc
  • Medical Director at Obsidian Therapeutics
    S. R.
    Medical Director
  • Senior Clinical Trial Manager at Obsidian Therapeutics
    L. M.
    Senior Clinical Trial Manager
  • Principal Scientist, Process Development at Obsidian Therapeutics
    B. O. R.
    Principal Scientist, Process Development

Obsidian Therapeutics Employee Metrics

100%
50%
0%
2026
2025
  • Research
  • Engineering
  • Operations
  • Quality Assurance
  • Manufacturing
  • Other
  • Finance
  • Program & Project Management
  • Biotechnology
  • Entrepreneurship
  • Administrative
  • Business
  • Legal

Contact profiles from Obsidian Therapeutics

Name
Title
Contact
Location
Last Update
  • Vice President Clinical Pharmacology; Toxicology; Quantitative Sciences at Obsidian Therapeutics
    G. H.
    Vice President Clinical Pharmacology; Toxicology; Quantitative Sciences
    Sep 01, 2026
  • Vice President, Clinical Operations & Translational Early Clinical Development at Obsidian Therapeutics
    P. P.
    Vice President, Clinical Operations & Translational Early Clinical Development
    Sep 01, 2026
  • Senior Vice President Head Of Research at Obsidian Therapeutics
    S. S.
    Senior Vice President Head Of Research
    Oct 22, 2024
  • Director Regulatory Affairs Cmc at Obsidian Therapeutics
    T. H.
    Director Regulatory Affairs Cmc
    Sep 01, 2026
  • Director Regulatory Affairs Cmc at Obsidian Therapeutics
    T. H.
    Director Regulatory Affairs Cmc
    Sep 01, 2026
  • Medical Director at Obsidian Therapeutics
    S. R.
    Medical Director
    Jun 29, 2026
  • Senior Clinical Trial Manager at Obsidian Therapeutics
    L. M.
    Senior Clinical Trial Manager
    Sep 01, 2026
  • Principal Scientist, Process Development at Obsidian Therapeutics
    B. O. R.
    Principal Scientist, Process Development
    Sep 01, 2026
  • Senior Scientist Cell Therapy Process Development at Obsidian Therapeutics
    B. O.
    Senior Scientist Cell Therapy Process Development
    Sep 01, 2026
  • Senior Scientist at Obsidian Therapeutics
    M. D.
    Senior Scientist
    Oct 22, 2024

Frequently Asked Questions

What is Obsidian Therapeutics known for?

Minus sign iconPlus sign icon
Obsidian Therapeutics was founded in 2015 and operates in the Biotechnology Research industry. Explore Obsidian Therapeutics's company overview page for more information.

What is Obsidian Therapeutics's most common email format?

Minus sign iconPlus sign icon
Obsidian Therapeutics employees' email format typically follows the pattern of FLast@obsidiantx.com. Trying to find reliable and up-to-date employee contact data? Find more Obsidian Therapeutics email formats with LeadIQ.

How many employees does Obsidian Therapeutics have currently?

Minus sign iconPlus sign icon
Obsidian Therapeutics has approximately 105 employees as of August 2026. These team members are located across 2 continents, including North America and Europe.

Who are Obsidian Therapeutics's key employees and leadership?

Minus sign iconPlus sign icon

As of August 2026, Obsidian Therapeutics's key employees include:

  • Vice President Clinical Pharmacology; Toxicology; Quantitative Sciences: G. H.
  • Vice President, Clinical Operations & Translational Early Clinical Development: P. P.
  • Senior Vice President Head Of Research: S. S.
  • Director Regulatory Affairs Cmc: T. H.
  • Director Regulatory Affairs Cmc: T. H.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.